Medicine Compliance Aid Stability
RetrovirViiV Healthcare UK Ltd
ViiV Healthcare UK Ltd
Capsules 100mg 250mg
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Zidovudine not adversely affected by short-term exposure to heat and sunlight. Capsules may become discolored or brittle and should be protected from light, heat, and moisture.
18 August 2015